AngioLab (XKRX:251280) YoY EBITDA Growth : -14.33% (As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is AngioLab YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. AngioLab's YoY EBITDA Growth for the quarter that ended in Dec. 2023 was -14.33%.

AngioLab's EBITDA per Share for the six months ended in Dec. 2023 was ₩-790.53.

AngioLab YoY EBITDA Growth Historical Data

The historical data trend for AngioLab's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AngioLab YoY EBITDA Growth Chart

AngioLab Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

YoY EBITDA Growth

Get a 7-Day Free Trial

21.60

109.37

-327.65

6.01

-14.33

AngioLab Semi-Annual Data
	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
YoY EBITDA Growth	Get a 7-Day Free Trial			21.60	109.37	-327.65	6.01	-14.33

AngioLab YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

AngioLab's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (A: Dec. 2023 )
=	(EBITDA per Share (A: Dec. 2023 )	-	EBITDA per Share (A: Dec. 2022 ))	/	\| EBITDA per Share (A: Dec. 2022 ) \|
=	(-790.531	-	-691.431)	/	\| -691.431 \|
=	-14.33 %

AngioLab's YoY EBITDA Growth for the quarter that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (Q: Dec. 2023 )
=	(EBITDA per Share (Q: Dec. 2023 )	-	EBITDA per Share (Q: Dec. 2022 ))	/	\| EBITDA per Share (Q: Dec. 2022 ) \|
=	(-790.531	-	-691.431)	/	\| -691.431 \|
=	-14.33 %

AngioLab YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of AngioLab's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

AngioLab (XKRX:251280) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AngioLab Inc (XKRX:251280) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

65 Techno 3ro, Suite 159, Hanshin S Mecca, Yuseong-gu, Doejeon, CHN

Website

http://www.angiolab.co.kr

AngioLab Inc is a biotechnology company. It develops products based on angiogenesis inhibitors. It discovers, develops, and markets anti-angiogenic candidates to inhibit the abnormal growth of new blood vessel.

AngioLab (XKRX:251280) Headlines

No Headlines